159 related articles for article (PubMed ID: 15754733)
1. Identification of IgG-immunocomplex macroprolactin with an immunometric "sandwich" system: technical and clinical considerations.
Amadori P; Dilberis C; Marcolla A; Pinamonti M; Menapace P; Valentini A
J Endocrinol Invest; 2004 Dec; 27(11):1022-8. PubMed ID: 15754733
[TBL] [Abstract][Full Text] [Related]
2. Macroprolactinemia: predictability on clinical basis and detection by PEG precipitation with two different immunometric methods.
Amadori P; Dilberis C; Marcolla A; Pinamonti M; Menapace P; Dal Bosco F
J Endocrinol Invest; 2003 Feb; 26(2):148-56. PubMed ID: 12739743
[TBL] [Abstract][Full Text] [Related]
3. Rapid detection of macroprolactin in the form of prolactin-immunoglobulin G complexes by immunoprecipitation with anti-human IgG-agarose.
Schiettecatte J; De Schepper J; Velkeniers B; Smitz J; Van Steirteghem A
Clin Chem Lab Med; 2001 Dec; 39(12):1244-8. PubMed ID: 11798085
[TBL] [Abstract][Full Text] [Related]
4. Macroprolactinemia: diagnostic, clinical, and pathogenic significance.
Shimatsu A; Hattori N
Clin Dev Immunol; 2012; 2012():167132. PubMed ID: 23304187
[TBL] [Abstract][Full Text] [Related]
5. Cross-reactivities of macroprolactin and big-prolactin in three commercial immunoassays for prolactin: a chromatographic analysis.
Ellis MJ; Reed MR; Livesey JH
Clin Biochem; 2007 Nov; 40(16-17):1285-90. PubMed ID: 17825807
[TBL] [Abstract][Full Text] [Related]
6. Identification of IgG-κ type macroprolactin found in the serum of an 8-year-old girl.
Nakano K; Moriyama T; Yasuda K; Shibuya H; Tajima T; Shigematsu A; Shimizu C
Clin Chim Acta; 2014 Jun; 433():206-8. PubMed ID: 24680931
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of autoantibodies and immunoglobulin G subclasses in women with suspected macroprolactinemia.
Yu C; Fan F; Hu S; Meng L; Xu D; Wang J; Chen L; Liu J; Dong Y; Lu Y; Shen M; Zhai Y; Cao Z
J Clin Lab Anal; 2020 Nov; 34(11):e23456. PubMed ID: 32597541
[TBL] [Abstract][Full Text] [Related]
8. Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays.
Smith TP; Suliman AM; Fahie-Wilson MN; McKenna TJ
J Clin Endocrinol Metab; 2002 Dec; 87(12):5410-5. PubMed ID: 12466327
[TBL] [Abstract][Full Text] [Related]
9. Clinical and biological characterization of macroprolactinemia with and without prolactin-IgG complexes.
De Schepper J; Schiettecatte J; Velkeniers B; Blumenfeld Z; Shteinberg M; Devroey P; Anckaert E; Smitz J; Verdood P; Hooghe R; Hooghe-Peters E
Eur J Endocrinol; 2003 Sep; 149(3):201-7. PubMed ID: 12943522
[TBL] [Abstract][Full Text] [Related]
10. Biologic activity and plasma clearance of prolactin-IgG complex in patients with systemic lupus erythematosus.
Leaños-Miranda A; Chávez-Rueda KA; Blanco-Favela F
Arthritis Rheum; 2001 Apr; 44(4):866-75. PubMed ID: 11315926
[TBL] [Abstract][Full Text] [Related]
11. Serum prolactin revisited: parametric reference intervals and cross platform evaluation of polyethylene glycol precipitation-based methods for discrimination between hyperprolactinemia and macroprolactinemia.
Overgaard M; Pedersen SM
Clin Chem Lab Med; 2017 Oct; 55(11):1744-1753. PubMed ID: 28236625
[TBL] [Abstract][Full Text] [Related]
12. Anti-prolactin (PRL) autoantibodies cause asymptomatic hyperprolactinemia: bioassay and clearance studies of PRL-immunoglobulin G complex.
Hattori N; Inagaki C
J Clin Endocrinol Metab; 1997 Sep; 82(9):3107-10. PubMed ID: 9284753
[TBL] [Abstract][Full Text] [Related]
13. Clinical and radiological findings in macroprolactinemia.
Isik S; Berker D; Tutuncu YA; Ozuguz U; Gokay F; Erden G; Ozcan HN; Kucukler FK; Aydin Y; Guler S
Endocrine; 2012 Apr; 41(2):327-33. PubMed ID: 22187359
[TBL] [Abstract][Full Text] [Related]
14. Detection of macroprolactinemia with the polyethylene glycol precipitation test in systemic lupus erythematosus patients with hyperprolactinemia.
Leaños-Miranda A; Pascoe-Lira D; Chávez-Rueda KA; Blanco-Favela F
Lupus; 2001; 10(5):340-5. PubMed ID: 11403264
[TBL] [Abstract][Full Text] [Related]
15. Characterization of macroprolactin and assessment of markers of autoimmunity in macroprolactinaemic patients.
Kavanagh-Wright L; Smith TP; Gibney J; McKenna TJ
Clin Endocrinol (Oxf); 2009 Apr; 70(4):599-605. PubMed ID: 18771565
[TBL] [Abstract][Full Text] [Related]
16. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: CLINICAL RELEVANCE OF MACROPROLACTIN IN THE ABSENCE OR PRESENCE OF TRUE HYPERPROLACTINEMIA.
Samson SL; Hamrahian AH; Ezzat S; ;
Endocr Pract; 2015 Dec; 21(12):1427-35. PubMed ID: 26642103
[TBL] [Abstract][Full Text] [Related]
17. The natural history of macroprolactinaemia.
Hattori N; Adachi T; Ishihara T; Shimatsu A
Eur J Endocrinol; 2012 Apr; 166(4):625-9. PubMed ID: 22247016
[TBL] [Abstract][Full Text] [Related]
18. Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers.
Hattori N; Ishihara T; Saiki Y
Clin Endocrinol (Oxf); 2009 Nov; 71(5):702-8. PubMed ID: 19486017
[TBL] [Abstract][Full Text] [Related]
19. Anti-prolactin (PRL) autoantibody-binding sites (epitopes) on PRL molecule in macroprolactinemia.
Hattori N; Nakayama Y; Kitagawa K; Ishihara T; Saiki Y; Inagaki C
J Endocrinol; 2006 Aug; 190(2):287-93. PubMed ID: 16899562
[TBL] [Abstract][Full Text] [Related]
20. A New Method of Using Polyethylene Glycol (PEG) Precipitation of Macroprolactin to Detect Genuine Hyperprolactinemia.
Chen Y; Wang H; Yang W; Jin W; Yu W; Wang W; Zhang K; Song G
J Clin Lab Anal; 2016 Nov; 30(6):1169-1174. PubMed ID: 27219457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
